Shin SS, Modongo C, Zetola NM. Twice-Daily vs. Once-Daily Dolutegravir in Patients With Human Immunodeficiency Virus-Tuberculosis Coinfection Receiving Rifampicin-Based Tuberculosis Therapy. Clin Infect Dis 2020 May 14. pii: 5836979. doi: 10.1093.
PMID: 32436563